FDA Recall of Heart Meds Grows Due to Cancer Risk

The US Food and Drug Administration (FDA) has expanded the list of recalled drugs commonly used to treat high blood pressure and heart failure because they contain a potential cancer-causing agent.

Aurobindo Pharma USA this week announced a voluntary recall of 78 valsartan tablets, and Torrent Pharmaceuticals expanded its voluntary recall of losartan potassium tablets to a total of 10 servings.

The continuous recall applies to angiotensin II receptor blockers (ARBs) that have been found to contain trace amounts of the chemicals N-nitrosodiethylamine (NDEA) or N-nitrosodimethylamine (NDMA) above acceptable daily intake levels.

NDEA was detected in these newly withdrawn drugs. The Food and Drug Administration describes it as “a naturally occurring substance in some foods, drinking water, air pollution, and industrial processes.” The agency suspects that carcinogens were introduced into the manufacturing process.

Related Articles

Leave a Reply

Your email address will not be published.

Back to top button